TNF as a therapeutic target

Bondeson, Jan, Feldmann, M. and Maini, R. N. 2000. TNF as a therapeutic target. Immunologist 8 (6) , pp. 136-140.

Full text not available from this repository.

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a well-recognized proinflammatory cytokine, and as such provides an ideal target for anti-inflammatory therapies. Recent developments have shown very exciting results, and in this article, Jan Bondeson, Marc Feldman, and Ravinder N. Maini review the outcome of clinical trials of anti-TNF-alpha therapies in a range of chronic inflammatory diseases.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Hogrefe & Huber
ISSN:	1192-5612
Last Modified:	30 Jun 2017 03:26
URI:	https://orca.cardiff.ac.uk/id/eprint/57660

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item